Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
Related press release
Associated XERS transcripts
XERS similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-262403 and 333-262404) on Form S-3 and (No. 333-263466) on Form S-8 of our report dated March 8, 2023, with respect to the consolidated financial statements of Xeris Biopharma Holdings, Inc.
/s/ KPMG LLP
Chicago, Illinois
March 8, 2023